Serino, Angeline T.
HRN: 27-16-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2025
CEFTRIAXONE 1G (VIAL)
09/16/2025
09/23/2025
IV
2g
OD
CAPMR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines